Real life efficacy of palbociclib and endocrine therapy in HR positive, HER2 negative advanced breast cancer

Real life efficacy of palbociclib and endocrine therapy in HR positive, HER2 negative advanced breast cancer

Background: Palbociclib is indicated for the treatment of hormone receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC), in combination with endocrine therapy. Emerging real-life data suggest that the efficacy of a palbociclib-based therapy is highly conserved. We report the In...

Full description

Bibliographic Details
Main Authors: B. Porte, M. Carton, F. Lerebours, E. Brain, D. Loirat, L. Haroun, A. Bellesoeur, S. Bach Hamba, Y. Kirova, P. Cottu
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:Breast
Subjects:
Advanced breast cancer
Palbociclib
Endocrine therapy
Real-life
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977620302149

Internet

http://www.sciencedirect.com/science/article/pii/S0960977620302149

Similar Items